Teva Pharmaceuticals News

Drug Manufacturer Teva to Pay $523M to New York in Opioid Settlement

Teva Pharmaceutical Industries Lts. will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the U.S. opioid epidemic. The settlement with New York adds an additional $300 …

New York Accuses Drug Firm Teva of Lying About Opioid Role

New York’s attorney general on Monday said Teva Pharmaceutical Industries Ltd. lied to evade accountability for helping fuel the state’s opioid crisis, and should be restored to litigation where the Israeli company’s U.S. unit had been found liable. In a …

Rhode Island Reaches $107M Opioid Settlements With Teva and Allergan

Rhode Island’s attorney general on Monday announced settlements he valued at $107 million against the drugmakers Teva Pharmaceutical Industries and AbbVie’s Allergan unit to resolve claims over their roles in fueling an opioid epidemic in the state. Attorney General Peter …

Trial Against Teva Begins in Rhode Island Multibillion-Dollar Opioid Case

Rhode Island is set to square off on Monday against Teva Pharmaceutical Industries Ltd., as a multibillion-dollar trial begins over whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two …

New York Jury Finds Drugmaker Teva Liable for Fueling Opioid Crisis

Teva Pharmaceutical Industries Ltd. fueled opioid addiction in New York state, a jury found last Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the United States. The verdict, which followed a nearly six-month New …

AbbVie Pays $200M to Settle Opioid Marketing Case Right Before Trial Ends

AbbVie Inc. agreed to pay $200 million to settle claims by New York that its Allergan unit helped fuel an epidemic of opioid addiction in the state, shortly before jurors heard closing arguments from remaining defendant Teva Pharmaceutical Industries Ltd. …

Appeals Court Reinstates Glaxo $235.5 Million Verdict Against Teva

A federal appeals court on Friday reinstated a 2017 jury verdict ordering Teva Pharmaceutical Industries Ltd. to pay GlaxoSmithKline Plc $235.5 million for selling a generic version of Glaxo’s heart drug Coreg. In a 2-1 decision, the U.S. Federal Circuit …

U.S. Charges Teva With Conspiring to Fix Generic Drugs Prices

The U.S. Justice Department charged Teva Pharmaceutical Industries Ltd. on Tuesday with conspiring with competitors to raise prices for generic drugs. The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of …

Four Drugmakers Reach $260M Settlement, Ending Opioid Trial Set to Start Today

Four large drug companies reached a last-minute $260 million legal settlement over their role in the U.S. opioid addiction epidemic, averting the first federal trial that was scheduled to start Monday morning in Cleveland. The settlement covers drug distributors and …

US Government Wants Some of Oklahoma’s $270M Purdue Pharma Settlement Money

The U.S. government wants a portion of Oklahoma’s $270 million settlement with Purdue Pharma that stemmed from the state’s ongoing lawsuit against opioid makers. The U.S. Centers for Medicare and Medicaid Services wrote to the head of Oklahoma’s Medicaid agency …